mpeboaia

first_imgCBJ Assembly Meetings | Community | Government | Juneau | Local GovernmentUCLA report examines sexual orientation and gender discrimination in AlaskaJuly 29, 2015 by Lakeidra Chavis, KTOO Share:An Alaska Pride flag. The image is based on a double-faced eagle design from Alaska before Russian contact. (Creative Commons photo by Mel Green)Last Wednesday, the University of California, Los Angeles, published a report on employment discrimination in Alaska based on sexual orientation and gender identity. Alaska is home to more than 19,000 lesbian, gay, bisexual and transgender adults, according to a Gallup poll.                                                                              The report, published by UCLA’s Williams Institute found that 17 out of Alaska’s 25 largest employers have corporate policies that prohibit discrimination based on sexual orientation. At least 11 of them list gender identity as a protected class. Some of these employers include Providence Health and Services, Wal-Mart, Fred Meyer and the Arctic Slope Regional Corporation.Christy Mallory co-authored the report, and says it took about a month to compile.The report predicts that if non-discrimination laws were expanded, approximately six complaints of sexual orientation or gender identity employment discrimination would be filed annually in Alaska.“So, six complaints is pretty low,” Mallory said, “that’s mostly because there’s a smaller population in Alaska than many other states.”The report also cites a 2012 web survey on LGBT discrimination in Anchorage.According to the Anchorage survey, 44 percent of the respondents had experienced harassment and nearly a fifth had been turned down for a job or promotion. The survey found that transgender people are more at risk for housing and employment discrimination.The report found that straight male workers’ income was 30 percent higher than gay male workers.Mallory says their reports focus on the 28 states that don’t offer LGBT legal protection in the workplace.In a 2011 poll, nearly 80 percent of Alaskans said Congress should pass a law to prohibit LGBT employment discrimination.In 2002, Gov. Tony Knowles issued an administrative order protecting state employees from employment discrimination and harassment. There are no restrictions on the private sector.Neither the Alaska State Commission for Human Rights or the Anchorage Equal Rights Commission processes discrimination claims based on sexual orientation or gender identity. But the Williams Institute says that this discrimination does take place, citing legislative testimony.Share this story:last_img read more

first_img Read This NextRicky Schroder Calls Foo Fighters’ Dave Grohl ‘Ignorant Punk’ forThe Wrap’Drake & Josh’ Star Drake Bell Arrested in Ohio on Attempted ChildThe WrapCNN’s Brian Stelter Draws Criticism for Asking Jen Psaki: ‘What Does theThe WrapDid Donald Trump Wear His Pants Backwards? Kriss Kross Memes Have AlreadyThe WrapHarvey Weinstein to Be Extradited to California to Face Sexual AssaultThe WrapKatt Williams Explains Why He Believes There ‘Is No Cancel Culture’ inThe WrapPink Floyd’s Roger Waters Denies Zuckerberg’s Request to Use Song in Ad:The Wrap’Black Widow’ First Reactions: ‘This Is Like the MCU’s Bond Movie’The Wrap’The View’: Meghan McCain Calls VP Kamala Harris a ‘Moron’ for BorderThe Wrap Balls hits back at Labour critics of mansion tax A ROW erupted in the Labour party yesterday over its key mansion tax proposal.The shadow chancellor Ed Balls insisted that “there’s a tried and tested way to do this. People will be able to get an independent evaluation, which HMRC will use….Of course it will work.”He was forced on to the defensive in response to a rare intervention by former business secretary Lord Mandelson. The Labour grandee called the policy “crude” and “short-termist”, and backed the Lib Dem proposal to raise council tax bands instead.The Lib Dems said that the “comments prove yet again that Labour is all at sea when it comes to the nation’s finances.” Other high profile Labour critics include Hackney MP Diane Abbott, who yesterday backed Lord Mandelson, calling the mansion tax policy a “tax on London” which could “have unforeseen effects.” However, Abbott’s potential rival to be Labour’s candidate for London Mayor Sadiq Khan disagreed, saying “the mansion tax is absolutely fair,” insisting that “those who are cash poor, but asset rich will not be affected.” Share Tuesday 20 January 2015 9:03 pm Express KCS by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeMaternity WeekA Letter From The Devil Written By A Possessed Nun In 1676 Has Been TranslatedMaternity WeekMoneyPailShe Was A Star, Now She Works In ScottsdaleMoneyPailElite HeraldExperts Discover Girl Born From Two Different SpeciesElite Heraldzenherald.comMeghan Markle Changed This Major Detail On Archies Birth Certificatezenherald.comEquity MirrorThey Drained Niagara Falls — They Weren’t Prepared For This Sickening DiscoveryEquity MirrorNoteableyKirstie Alley Is So Skinny Now And Looks Like A BarbieNoteableyBeverly Hills MDPlastic Surgeon Explains: “Doing This Every Morning Can Snap Back Sagging Skin” (No Creams Needed)Beverly Hills MDVikings: Free Online GameIf you’re over 50 – this game is a must!Vikings: Free Online GameUltimate Pet Nutrition Nutra Thrive SupplementIf Your Dog Eats Grass (Do This Every Day)Ultimate Pet Nutrition Nutra Thrive Supplementcenter_img whatsapp whatsapp Show Comments ▼ Tags: NULLlast_img read more

first_img NewslettersSign up for The Readout Your daily guide to what’s happening in biotech. David Silverman/Getty Images People grumble a lot about the shortcomings of the flu vaccine, which some years offers less protection than expected. (Warning: This year may be one of them.) What they may not know is that the source of at least some of the problems is a common item found in all grocery stores and many fridges.The egg.The overwhelming majority of flu vaccines are made from viruses grown in eggs. This production process is inexpensive and time-tested; flu vaccines have been made this way as long as flu vaccines have been made.advertisement Related: But the process is not ideal — and it leads to issues that can undermine the vaccine’s effectiveness. Increasingly, experts are questioning whether the pros of egg production are worth putting up with the cons.“We need to do a lot to improve existing vaccines. And getting away from eggs would be very valuable,” said Dr. Kanta Subbarao, director of the World Health Organization’s influenza collaborating center in Australia.advertisement Related: Privacy Policy Helen Branswell Dr. Daniel Jernigan, CDC By Helen Branswell Nov. 7, 2017 Reprints Researchers in the U.S., Canada, and parts of Europe conduct studies every year that estimate how effective flu vaccine was at preventing illness. But those studies are not enormous and most of the people in them would be getting flu vaccine produced in eggs, so teasing out an answer from that research may not be possible.Manufacturers themselves could study the question, and in a very crowded flu vaccine market may actually have motivation to do so. The CDC’s Jernigan noted that a few years back Sanofi Pasteur, the largest supplier of flu vaccine, funded a trial that compared a high-dose formulation it wanted to sell to seniors against its regular vaccine. The high-dose vaccine was found to be more effective, and the company is allowed to target individuals 65 and older, the demographic most likely to get flu shots.Studies that show convincingly that flu vaccines produced in cell culture or using other non-egg methods are better could lead the expert panel that counsels the CDC on vaccines, the Advisory Committee on Immunization Practices, to preferentially recommend those vaccines over vaccines produced in eggs.“I think that kind of pressure — if there are preferential recommendations related to that — will drive change in industry,” said Dr. Danuta Skowronski, an influenza expert at the British Columbia Center for Disease Control and lead author of a study that showed an egg-mutation problem in the 2012-2013 flu season.Others aren’t so sure the industry would be willing to make a major production shift, which would require manufacturers to conduct expensive trials, apply for new regulatory licenses, and build and certify new production facilities. How does the flu vaccine work?Volume 90%Press shift question mark to access a list of keyboard shortcutsKeyboard ShortcutsEnabledDisabledPlay/PauseSPACEIncrease Volume↑Decrease Volume↓Seek Forward→Seek Backward←Captions On/OffcFullscreen/Exit FullscreenfMute/UnmutemSeek %0-9 facebook twitter Email Linkhttps://www.statnews.com/2017/11/07/flu-vaccine-egg-production/?jwsource=clCopied EmbedCopiedLive00:0000:4900:49  The vaccine triggers the immune system to create antibodies, preparing the body for viral battle. Alex Hogan/STAT “It’s a pretty big manufacturing lift. Or at least regulatory lift,” Jernigan said.The other hurdle is the fact that many in industry, government, and public health have their eyes on a bigger prize. Rather than a small change that might offer modest improvements to the performance of flu vaccines, they’re looking to a radical shift — a flu vaccine that offers long-term protection against most or all known flu viruses. It’s the Holy Grail of flu, the so-called universal vaccine.“In some ways, the whole discussion now about universal or game-changing vaccine has somewhat shifted the landscape. Because now people are going to say, ‘Wait a minute. Am I going to invest in an intermediate stage of vaccine production … and do this kind of fix on the current vaccine as an intermediate stage or interim stage?’” said Michael Osterholm, director of the Center for Infectious Diseases Research and Policy at the University of Minnesota.“This is where you’re talking about the business of vaccines as much as you are the science. The business of the vaccine has been in part why we haven’t seen the science further along. Everybody felt like they had a nice business model going with what they had.” Flu experts see potential for a nasty winter season Leave this field empty if you’re human: Producing too much of the nation’s ​flu vaccine supply in a single medium is literally as dangerous as putting all your eggs in one basket — especially given that some of the flu viruses that threaten to cause pandemics, such as H5N1 and H7N9, infect chickens, either killing them or reducing egg production.“When I look at a need to produce 600 million doses of influenza vaccine in a very short timeline of a pandemic, it’s going to be really important that we have all horses in the race. So eggs and cells and recombinant,” said BARDA Director Rick Bright.“Some [flu viruses] might grow well in eggs and some well in cells, and some better in recombinant systems,” he said. “So that’s been part of our strategy to make more capacity available domestically and also to diversify this for the various unpredictable attributes of influenza.”There are a few key hurdles for those interested in seeing more seasonal production move out of eggs. The first is that there isn’t much evidence yet that the vaccines produced in other mediums perform better than those made in eggs. Experts believe the FluBlok and Flucelvax may be more effective against H3N2 viruses this winter than the egg-based vaccines, but companies won’t be motivated to make what would be a very expensive production shift on belief alone.In fact, some companies that had been working on cell culture flu vaccines abandoned the work. “There wasn’t convincing evidence that it was better so why would anyone spend extra money to buy that?” noted Dr. John Treanor, a flu vaccine expert at the University of Rochester.“The business case was tough, and I think a lot of these enterprises did not make it partially because of that.”To be clear, it’s not that these vaccines have been shown to be less effective or no more effective than vaccines produced in eggs. It’s that in the main, proof that they are better is sparse to date. “If you were to start now with a new vaccine for flu, would it be grown in eggs? No.” Please enter a valid email address. To produce flu vaccine, most manufacturers must grow lots of flu viruses, which are later killed or weakened before they are put into the vaccine. In all but a few cases, those viruses are grown in hens’ eggs.But flu viruses must mutate — adapt — to grow inside eggs. Sometimes those mutations aren’t huge or aren’t on important spots on the virus and they don’t undermine the effectiveness of the vaccine. But when they are, the impact can be substantial. It’s as if the antibodies the vaccine generates are looking for Superman — but they encounter Clark Kent. The glasses, the suit, the tie confuse them; the antibodies don’t see Superman and the mild-mannered newsman as the same person and they don’t respond.Researchers have known for a while that this can happen. In a study released just Monday, scientists said that the disappointing performance of the vaccine last year was the result of a mutation that developed when the viruses for the vaccine were grown in eggs. The upshot: The antibodies generated by the H3N2 vaccine didn’t adequately target the viruses that were making people sick. Will this be a miserable flu season?Volume 90%Press shift question mark to access a list of keyboard shortcutsKeyboard ShortcutsEnabledDisabledPlay/PauseSPACEIncrease Volume↑Decrease Volume↓Seek Forward→Seek Backward←Captions On/OffcFullscreen/Exit FullscreenfMute/UnmutemSeek %0-9 facebook twitter Email Linkhttps://www.statnews.com/2017/11/07/flu-vaccine-egg-production/?jwsource=clCopied EmbedCopiedLive00:0001:5401:54  STAT reporter Helen Branswell explains why it’s so difficult to predict the severity of the upcoming flu season. Alex Hogan/STAT The H3N2 component in this year’s flu vaccine is identical to the one in last winter’s, so the vaccine could fail to provide strong protection again if H3N2 flu viruses are in high circulation this winter.“To make a prediction about this flu season, it does appear if H3s do circulate, there will be this problem of this egg mutation,” said Scott Hensley, an associate microbiology professor at the University of Pennsylvania and senior author of the study, which was published in the Proceedings of the National Academy of Sciences.Moving out of egg-based production would improve the performance of the vaccine, many experts believe. About the Author Reprints Officially, the Centers for Disease Control and Prevention doesn’t have a preference for how flu vaccine is made — as long as the resulting product is safe and effective. But if you ask Dr. Daniel Jernigan, director of the CDC’s influenza division, if eggs are the future of flu vaccines, his answer is telling.“If you were to start now with a new vaccine for flu, would it be grown in eggs? No,” Jernigan said.The U.S. government office charged with preparing the country to deal with public health emergencies like flu pandemics has recognized the limitations of egg-based flu vaccine production for a while. For more than a decade BARDA — the Biomedical Advanced Research and Development Authority — has been working with manufacturers to encourage them to move some portion of production out of eggs.Its funding helped foster development of the two flu vaccines on the market that aren’t made in eggs — FluBlok, a recombinant vaccine developed by Protein Sciences (recently acquired by Sanofi Pasteur) and Flucelvax, produced in the U.S. by the Australian company Seqirus.The former is made of influenza hemagglutinin proteins — the main target of flu vaccines — that are generated by viruses that infect insect cells, while the latter is made of flu viruses grown in dog kidney cell lines.(Any time flu viruses have to adapt to grow in the cells of a new host — as in the case of the dog kidney cells — there can be mutations. But the egg-induced mutations seem more problematic. “I think historically just what we know about putting flu viruses in cells versus putting them in eggs is that generally the stability of the sequence is greater in mammalian cells,” said Jacqueline Katz, deputy director of CDC’s influenza division.) In the LabHow the incredible, edible egg may actually be hampering your flu vaccine Senior Writer, Infectious Disease Helen covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. New flu findings may threaten prospects for universal vaccine @HelenBranswell Tags pharmaceuticalsVaccineslast_img read more

first_imgOther appointees include well-known public health officials such as Julie Morita, a former Chicago health commissioner, and Eric Goosby, the founding director of the federal government’s Ryan White HIV/AIDS program.The task force also includes a variety of other well-known doctors and academics, among them Zeke Emanuel, a former Obama administration health care adviser, and Celine Gounder, a physician and medical journalist with years of experience combating HIV and tuberculosis outbreaks. Separately, the Biden transition announced that it had appointed two health advisers who will guide the incoming administration’s Covid-19 preparations but will not serve on the task force. One of those advisers, Beth Cameron, is the former director of a White House biodefense council that Trump has been criticized for closing in 2017. The other, Rebecca Katz, is a well-known Georgetown global health security professor. Despite the task force’s breadth, it does not include several figures still seen as likely to play major roles in the Biden administration’s Covid-19 effort, including Joshua Sharfstein, the former deputy FDA commissioner, and Nicole Lurie, the Obama administration’s assistant health secretary for preparedness and response.Below is the full list of task force members:David Kessler, co-chair, former FDA commissionerMarcella Nunez-Smith, co-chair, Yale associate dean for health equity research Vivek Murthy, co-chair, former surgeon general Luciana Borio, former assistant FDA commissioner Rick Bright, former BARDA director Zeke Emanuel, former Obama administration health policy adviserAtul Gawande, Brigham and Women’s hospital professor of surgery Celine Gounder, NYU Grossman School of Medicine assistant professorDr. Julie Morita, former Chicago public health commissioner Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of MinnesotaLoyce Pace, executive director of the Global Health CouncilDr. Robert Rodriguez, UCSF emergency medicine professor Eric Goosby, former Ryan White Care Act director Related: “Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts,” Biden said in a statement Monday. “The advisory board will help shape my approach to managing the surge in reported infections; ensuring vaccines are safe, effective, and distributed efficiently, equitably, and free; and protecting at-risk populations.” Washington Correspondent Lev Facher covers the politics of health and life sciences. HealthBiden transition team unveils members of Covid-19 task force Lev Facher @levfacher Rick Bright, the former head of the vaccine-development agency BARDA, is among the members of the new task force. GREG NASH/POOL/AFP via Getty Images By Lev Facher Nov. 9, 2020 Reprints WASHINGTON — President-elect Biden’s transition team unveiled the members of his Covid-19 task force on Monday, a who’s-who of former government health officials, academics, and major figures in medicine.The list includes Rick Bright, the former head of the vaccine-development agency BARDA ousted by the Trump administration in April; Atul Gawande, the surgeon, writer, and recently departed CEO of Haven, the joint JP Morgan Chase-Berkshire Hathaway-Amazon health care venture; and Luciana Borio, a former Food and Drug Administration official and biodefense specialist. Biden has cast the escalating Covid-19 crisis as a priority for his incoming administration. The task force, he said, would quickly consult with state and local health officials on how to best prevent coronavirus spread, reopen schools and businesses, and address the racial disparities that have left communities of color harder hit than others by the pandemic. advertisement Tags Coronavirus About the Author Reprints A lucrative Regeneron contract with the federal government lacks the usual taxpayer protections As expected, the board’s three co-chairs are Marcella Nunez-Smith, a Yale physician and researcher; Vivek Murthy, a former U.S. surgeon general; and David Kessler, a former FDA commissioner. advertisement [email protected] last_img read more

Economy lost 68,000 jobs in May Share this article and your comments with peers on social media Stagflation is U.S. economists’ biggest fear, SIFMA says Related news James Langton Moody’s notes that yesterday’s package does not address the federal government’s statutory debt limit, which was reached on December 31. “The need to raise the debt limit may affect the outcome of future budget negotiations,” it notes. While the fiscal package raises some revenue through higher tax rates on high earners, Moody’s says “the estimated amount of increased revenue over the next decade is far outweighed by the amount of revenue foregone through the extension of lower tax rates for those with incomes below $400,000, the indexation of the alternative minimum tax, and other measures.” Moody’s estimates that the ratio of government debt to GDP would peak at about 80% in 2014 and then remain in the upper 70% range for the remaining years of the coming decade. “Stabilization at this level would leave the government less able to deal with future pressures from entitlement spending or from unforeseen shocks. Thus, further measures that bring about a downward debt trajectory over the medium term are likely to be needed to support the Aaa rating,” it says. Additionally, the rating agency notes that the macroeconomic effects of the package are positive, “since it averts the recession that would likely have occurred had personal income taxes gone up for all income levels”. However, it adds that the increase in the Social Security payroll tax will likely be a constraint on growth in coming quarters. And, spending cuts that may be decided in coming months could also affect the rate of GDP growth in the near term, it says. “Overall, therefore, the recent package mitigates part of the fiscal drag on the economy associated with the fiscal cliff but does not eliminate it,” it concludes. Moreover, the debt limit will have to be raised in February or early March, it says, adding, “… it seems likely that new measures addressing the expenditure side of the budget will be negotiated at around the time the debt limit will need to be raised.” Although Moody’s says it believes that the debt limit will eventually be raised and that the risk of default on Treasury bonds is extremely low, “this confluence of events adds uncertainty to the outcome of negotiations,” it adds. “The debt trajectory resulting from this process is likely to determine whether the Aaa rating is returned to a stable outlook or downgraded to Aa1,” Moody’s says. While U.S. lawmakers managed to avoid going over the fiscal cliff, Moody’s Investors Service says that the agreement still doesn’t provide a basis for a meaningful improvement in the government’s debt ratios over the medium term. The rating agency said Wendesday it expects that further fiscal measures are likely to be taken in coming months that would result in lower future budget deficits, which are necessary if the negative outlook on the government’s bond rating is to be returned to stable. “On the other hand, lack of further deficit reduction measures could affect the rating negatively,” it says. OECD raises outlook for Canadian economic growth this year Keywords Economic forecasts Facebook LinkedIn Twitter read more

first_img Keywords Embedded commissions Leah Golob The proposed ban on embedded commissions was a hotly debated topic at the 2017 Inflection Point Advocis Symposium in Toronto on Tuesday. Facebook LinkedIn Twitter Many cases have been made on both sides of the discussion about whether a ban on embedded commissions in investment products would be good for clients and, ultimately, the industry. Speakers at this event represented a variety of perspectives and opinions. Peter Intraligi, president of Toronto-based Invesco Canada Ltd. said in an interview-format presentation that banning commissions would hurt small investors because they would be required to pay more money for advice, potentially creating an “advice gap” in the market. A balanced solution, he said, would be to standardize the trailer fees that are embedded in mutual funds. “In our view,” Intraligi said, “the conflict [of interest] is created when you have a difference in fees that are being charged.” For example, if choosing between two mutual funds with similar investment and performance styles that differ only in trailer fees, an advisor might lean toward the fund with the higher-paying trailer. “Our view,” Intraligi said, “is that when [one standard fee] is embedded in the price of a fund — say 1% — that eliminates the potential for conflict.” Intraligi was careful to note, however, that he is not suggesting capping advisor compensation. If an advisor provides services that exceed the 1% fee embedded in the fund, the advisor can go to fee-based platform and charge whatever he or she deems appropriate. “In our view,” he said, “it gives you some flexibility.” In a separate panel discussion at the event, Wanda Morris, vice president of advocacy for CARP (formerly the Canadian Association of Retired Persons), refuted the idea that a standard fee would eliminate any conflicts of interest. A standard fee, Morris said, would only remove a conflict of interest within a particular product category, such as mutual funds, but not between product categories. For example, she drew attention to the relative lack of ETF investments in Canada, which are a lower-cost alternative to mutual funds. Many clients, she said, are put into mutual funds that essentially mimic ETFs, but with a higher cost. “Probably every week I get a letter, email or call from a [CARP] member who has not been well served by our current regulatory structure,” she said. CARP members are largely in favour of removing embedded commissions, she added. A recent poll of CARP members revealed that 79% supported the ban on embedded fees. “I believe I speak for [CARP members] in saying they would be more than willing to pay fees to make sure their assets are managed wisely through the decumulation stage and that they’re making the right decisions,” she added. Lawrence Haber, a member of the Ontario Expert Committee to Consider Financial Advisory and Financial Policy Alternatives, also supported the idea of banning embedded commissions, in a separate presentation. Haber said he does not support the suggestion that removing embedded commissions would lead to an advice gap in the market. He believes advisors could still charge fees without an embedded commission. While many in the industry have argued that clients are going to balk at fees if they’re not embedded, Haber said, advisors can soften the blow by charging fees on a monthly basis instead of in one lump sum. For example, he said, if an advisor is receiving $600 in annual trailer fees on a $50,000 account, why not break up that amount into 12 monthly payments — of $50. “Then you’ve charged them based on a trailer and you haven’t changed the compensation,” he said. “You’ve changed the methodology.” “Let’s stop fighting about embedded commissions,” Haber concluded, “and move toward transparency.” Photo: Advocis Share this article and your comments with peers on social media Related news Proposed class action against Mackenzie seeks $175 million in damages Investor submissions to proposed DSC ban reveal anger, frustration Discount brokers face trailer-fee class actionlast_img read more

first_imgWall street sign in New York with American flags and New York Stock Exchange background. kasto/123RF Facebook LinkedIn Twitter Specifically, FINRA is concerned that some firms claim that they are not selling or recommending securities through their involvement with online distribution platforms, the letter states, “despite evidence to the contrary, including handling customer accounts and funds, or receiving transaction-based compensation.”Regarding online distribution, FINRA says that it will look at a variety of issues including firms’ compliance with suitability requirements, the risk of undisclosed compensation arrangements, and the quality of product disclosure, among other things.Other emerging issues identified in the letter as areas of focus in 2019 are: firms’ compliance with FinCEN’s Customer Due Diligence (CDD) rule; and firms’ compliance with their mark-up or mark-down disclosure obligations on fixed income transactions with customers.In addition, FINRA will continue to review for firms’ compliance in important areas of focus identified in prior years, including sales practice risks; hiring and supervision of associated persons with a problematic regulatory history; cybersecurity; and fraud, insider trading and manipulation across markets and products.“While we will continue to review and examine for longstanding priorities discussed in greater detail in past letters, we agree with the suggestion from many of our member firms that a sharper focus on emerging issues will help them better determine whether those issues are relevant to their businesses and how they should be addressed,” says Robert Cook, FINRA CEO, in a statement. Share this article and your comments with peers on social media Robo-advisors, fixed-income disclosure and sales practices are among the key areas of focus for the Financial Industry Regulatory Authority’s (FINRA) compliance exams in 2019, the U.S. self-regulatory organization (SRO) announced Tuesday.In a letter setting out its exam priorities for the coming year, FINRA highlights both emerging and ongoing issues. Among emerging issues, the SRO points to the growth in online securities distribution. Related newscenter_img Keywords ComplianceCompanies Financial Industry Regulatory Authority Conflicts, crypto, cyber risk: the year ahead in compliance Regulators aim to root out pandemic-driven liquidity issues SEC examines rules for inter-fund tradinglast_img read more

first_img Facebook LinkedIn Twitter Share this article and your comments with peers on social media The co-op’s operating income increased by 6.9% year over year to $4.3 billion.The property and casualty insurance segment saw a loss of $81 million, compared to a $26-million profit a year ago.“Despite the impact of weather conditions on our results in property and casualty insurance, Desjardins performed well in the first quarter due to its highly diversified activities and the good results posted by the other business segments,” president and CEO Guy Cormier said in a statement.The co-op said it’s monitoring the flooding in Ontario, Quebec and New Brunswick and, based on the available information, “the floods themselves will not have a significant impact on Desjardins Group’s financial results.” Desjardins Group’s $401 million net income for the first quarter was $100 million lower than the same period last year due to property and casualty insurance claims, the co-op said Tuesday.Desjardins’ first-quarter results also showed a decline in profit from the wealth management and life and health insurance segment. Net income for the quarter that ended March 31 was $139 million for that segment, compared to $206 million a year ago. The earnings release said the decline was due to smaller gains from the disposal of securities and real estate investments. Related news Canaccord reports record revenues, drops proposal to acquire RF Capital IE Staff Canadian banks to focus on growth, spending and buybacks after strong second quarter Calculator pen, balance sheet and statistics for sales and taxes ginasanders/123RF Keywords EarningsCompanies Desjardins Group Laurentian Bank reports $53.1M profit in Q2, beats expectationslast_img read more

first_imgForeshore camping to resume in January Foreshore camping at Shire managed reserves in Rye, Rosebud and Sorento will resume on 2 January 2021.The decision was taken after undertaking a detailed risk assessment following the State Government’s Coronavirus roadmap announcement of Sunday 22 November.Mornington Peninsula Shire CEO John Baker said the overall easing of restrictions and in particular an increase in outdoor gathering numbers guided our thinking.“We have been monitoring the situation on a weekly basis with the health and wellbeing of our community, campers, visitors and staff at the forefront of our thinking. After reviewing the details in the Premier’s recent announcement and considering the risks, we concluded it was safe to resume camping, albeit with some ongoing Covid requirements in place.“I’m delighted we can allow the camping tradition to continue on the Peninsula this summer and I implore our campers to do the right thing to ensure a safe and successful season”.Campers who had pre-booked for January will be contacted to determine if they wish to reactivate their booking. It is estimated that the camp grounds will operate at approximately 80% capacity to support social distancing and to ensure adequate space between sites. There will be no casual booking offered at this stage.Campers will be asked to observe a number of Covid requirements such as a guest register for each site, complying with density quotients in amenity blocks and the wearing of masks where appropriate. They are also being encouraged to pack light and limit the use of extra equipment and kit to maintain a clear distance between sites.The shire will be introducing additional cleaning of amenity blocks.Mr Baker said ongoing concerns about the intermingling of beach goers and campers remain which is why the 2 January date was chosen.“We determined that the large numbers of people who gather on the beach between Christmas and New year, plus New Year’s Eve activities posed a significant risk of over crowding in and around the campgrounds.“We have been cautious with our deliberations and believe we have reached the right balance between public safety and allowing the camping season to continue”.The Shire will continue to monitor the advice from the Chief Health Officer and update campers and the community if circumstances change. /Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here. Why?Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don’t put up a paywall – we believe in free access to information of public interest. Media ownership in Australia is one of the most concentrated in the world (Learn more). Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. According to independent assessment, about 98% of the media sector is held by three conglomerates. This tendency is not only totally unacceptable, but also to a degree frightening). Learn more hereWe endeavour to provide the community with real-time access to true unfiltered news firsthand from primary sources. It is a bumpy road with all sorties of difficulties. We can only achieve this goal together. Our website is open to any citizen journalists and organizations who want to contribute, publish high-quality insights or send media releases to improve public access to impartial information. You and we have the right to know, learn, read, hear what and how we deem appropriate.Your support is greatly appreciated. All donations are kept completely private and confidential.Thank you in advance!Tags:beach, camping, community, coronavirus, Government, health, local council, Mornington Peninsula, Premier, risk assessment, Safety, season, social distancing, space, Victoria, wellbeinglast_img read more

first_imgShare Share via TwitterShare via FacebookShare via LinkedInShare via E-mail Categories:Lectures & PresentationsEvents & Exhibits Published: Sept. 19, 2016 center_img Science Learner’s Lunch is a workshop series designed to provide students with tools and information that complements the skills they learn in the classroom. The workshops take place every Wednesday, at 12 p.m., in Math 150, inside the Leonard H. Gemmill Library of Enigneering, Mathematics & Physics.Upcoming Science Learner’s Lunch WorkshopsSept. 21: Basic Zotero. Zotero makes managing your research easy by helping you cite sources and track your citations. In this workshop, you’ll install Zotero, learn to add materials, like journal articles and books, and generate bibliographies.Sept. 28: Advanced Zotero. Zotero can do much more that creating bibliographies and citations. In this advanced Zotero, you’ll learn to back-up PDFs, extract annotations using ZotFile, and other tricks that will make Zotero indispensable to your literature research.Oct. 5: Implicit Bias at Benson 380. The Leonard H. Gemmill Library of Engineering, Math & Physics is partnering with the BOLD Center and NCWIT to provide a workshop on practical ways you can contribute to a more inclusive college and combat implicit bias and inequality on campus. This workshop is taking place at Benson 380.Oct. 12: Introduction to ArcGIS. Learn to use ArcGIS Online to map your data quickly and easily. This workshop will cover setting up an account through creating data maps. Please RSVP to Phil White ([email protected]) within three days of the workshop so your free CU Boulder ArcGIS account can be created.Oct. 19: Building Your Professional Identity. Building and managing your scholarly and professional profile takes time. In this workshop, we’ll help you choose the best time-saving tools for your personal needs. You’ll be able to build your reputation and share your research with ease.Oct. 26: SciFinder for Chemical Engineers. Make the most of SciFinder’s unique features to quickly and powerfully search for chemical data and literature. Sign up for a SciFinder account before this workshop for best results. Sign up for SciFinder. Nov. 2: Demystifying Patent Searches. Patents are on the cutting edge of technology and have information that isn’t available in published journal literature. Learn how to search for patents and find out which ones are useful for entrepreneurial engineers.Nov. 9: Data Visualization Tools. Use data visualization tools to create new and unique ways to present your data. In this session we’ll focus on Gephi and Tableau Online. Please have Gephi (it’s free!) installed on your computer for best results.Nov. 16: Productivity Tools. Be a more productive student! Impress your professors and your peers! In this workshop you will get hands-on experience using productivity tools that will keep you organized and on top of your work.Nov. 30: QGIS: an Open Source GIS Platform. Map your data with the easy, platform spanning, and extensive functionality of QGIS. In this workshop we will introduce the QGIS interface and guide you through common GIS procedures. Please have QGIS (it’s free!) installed on your computer for best results. Contact Phil White, [email protected] if you need assistance installing the software.last_img read more